William F. Doyle, Executive Chairman at NovoCure Ltd (NVCR), sold 1,792 shares at $76.39 ($137K) on 2020-07-31, disclosed to the SEC on 2020-08-03.
Open-market sale of $137k NVCR by Executive Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $76.39 | 896 | $68K | 50.0% |
| 2 | $76.39 | 896 | $68K | 50.0% |
| Total | $76.39 avg | 1,792 | $137K | 100% |
| Filing → |
| ELAN | BUY | 2024-03-12 | $245K | — | Filing → |
| NVCR | SELL | 2022-08-03 | $117K | — | Filing → |
| NVCR | SELL | 2022-03-09 | $334K | — | Filing → |